Paper20200325
Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study.
Loughlin J and 7 others. J Cardiovasc Pharmacol Ther, 2010. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study. Papers, record 20200325. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20200325
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Agents | Major topic |
| Indoles | Major topic |
| Myocardial Ischemia | Major topic |
| Stroke | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Child | |
| Child, Preschool | |
| Cohort Studies | |
| Female | |
| Humans | |
| Infant | |
| Insurance Claim Review | |
| Male | |
| Middle Aged | |
| Sex Factors | |
| Young Adult |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37762575 | Small Organic Compounds Mimicking the Effector Domain of Myristoylated Alanine-Rich C-Kinase Substrate Stimulate Female-Specific Neurite Outgrowth. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762575 | PubMed |
| 35207632 | Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics. | J Pers Med | 2022 | https://conductscience.org/library/papers/35207632 | PubMed |
| 34683919 | Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer's Disease Treatment. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34683919 | PubMed |
| 34047303 | Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials. | Am J Gastroenterol | 2021 | https://conductscience.org/library/papers/34047303 | PubMed |
| 32691294 | Functional Dyspepsia: Diagnostic and Therapeutic Approaches. | Drugs | 2020 | https://conductscience.org/library/papers/32691294 | PubMed |
| 32085796 | Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications. | J Exp Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32085796 | PubMed |
| 31897312 | Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials. | Sultan Qaboos Univ Med J | 2019 | https://conductscience.org/library/papers/31897312 | PubMed |
| 31485565 | Opioid-Induced Hypogonadism in the United States. | Mayo Clin Proc Innov Qual Outcomes | 2019 | https://conductscience.org/library/papers/31485565 | PubMed |
| 30522596 | Management Options for Irritable Bowel Syndrome. | Mayo Clin Proc | 2018 | https://conductscience.org/library/papers/30522596 | PubMed |
| 30205698 | Testosterone replacement therapy and hospitalization rates in men with COPD. | Chron Respir Dis | 2019 | https://conductscience.org/library/papers/30205698 | PubMed |
| 29930260 | New treatments and therapeutic targets for IBS and other functional bowel disorders. | Nat Rev Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/29930260 | PubMed |
| 29147138 | An update on prucalopride in the treatment of chronic constipation. | Ther Adv Gastroenterol | 2017 | https://conductscience.org/library/papers/29147138 | PubMed |
| 28928800 | Weikangning therapy in functional dyspepsia and the protective role of Nrf2. | Exp Ther Med | 2017 | https://conductscience.org/library/papers/28928800 | PubMed |
| 27371355 | Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study. | Am J Obstet Gynecol | 2016 | https://conductscience.org/library/papers/27371355 | PubMed |
| 27325124 | Hypogonadism and the risk of rheumatic autoimmune disease. | Clin Rheumatol | 2016 | https://conductscience.org/library/papers/27325124 | PubMed |
| 27313955 | Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study. | Scientifica (Cairo) | 2016 | https://conductscience.org/library/papers/27313955 | PubMed |
| 27099579 | Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies. | Gastroenterol Hepatol (N Y) | 2015 | https://conductscience.org/library/papers/27099579 | PubMed |
| 26576134 | Recent Updates on the Treatment of Constipation. | Intest Res | 2015 | https://conductscience.org/library/papers/26576134 | PubMed |
| 25953004 | Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years. | J Pediatr | 2015 | https://conductscience.org/library/papers/25953004 | PubMed |
| 25729103 | Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010. | Public Health Rep | 2015 | https://conductscience.org/library/papers/25729103 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20200325
GET https://conductscience.org/api/papers/v1/20200325/cited_by?page=2